Tech Company Financing Transactions
Thesis Funding Round
Thesis closed a $8.4 million Series A financing round on 5/2/2023. Investors included Alive Venture, Break Trail Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/2/2023
Transaction Type
Venture Equity
Amount
$8,400,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand out its product selection and clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
902 Broadway Floor 6
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Website
Email Address
Overview
Thesis is the world's first personalized brain supplement brand. We understand that everyone's brains are unique and cognitive demands for daily tasks are constantly changing. Our nootropics are a powerful alternative to stimulants, providing similar benefits, minus the jitters, crash, and side effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Freed
Co-Founder
Adam Greenfeld
Browse more venture capital transactions:
Prev: 5/2/2023: SMPnet venture capital transaction
Next: 5/2/2023: Autonomize AI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs